1. Home
  2. EVC vs MDWD Comparison

EVC vs MDWD Comparison

Compare EVC & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$3.05

Market Cap

233.8M

Sector

Industrials

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.79

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
MDWD
Founded
1996
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Broadcasting
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.8M
238.5M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
EVC
MDWD
Price
$3.05
$18.79
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$37.50
AVG Volume (30 Days)
309.5K
82.4K
Earning Date
11-04-2025
11-20-2025
Dividend Yield
6.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$420,178,000.00
$20,932,000.00
Revenue This Year
$64.06
$15.89
Revenue Next Year
N/A
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
24.96
6.15
52 Week Low
$1.58
$14.14
52 Week High
$3.44
$22.51

Technical Indicators

Market Signals
Indicator
EVC
MDWD
Relative Strength Index (RSI) 57.47 54.69
Support Level $3.09 $18.55
Resistance Level $3.10 $18.96
Average True Range (ATR) 0.13 0.57
MACD -0.03 0.01
Stochastic Oscillator 35.04 55.79

Price Performance

Historical Comparison
EVC
MDWD

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: